Punjab witnessing unprecedented development: CM Bhagwant Mann
Mann visited his village here in Sangrur district to review the ongoing development works in the Dirba Assembly segment.
Satauj (Punjab), Aug 10 (PTI) Punjab Chief Minister Bhagwant Mann on Sunday said the state is witnessing 'unprecedented' development in every sphere and that massive projects are going on to accelerate its pace of growth.
The projects have been conceived keeping in view the larger public interest and to give fillip to the ongoing development of the state, Mann said, adding that there is no dearth of funds for such development works and more such projects will be dedicated to the public in the coming days.
In the agricultural sector, the chief minister said he had promised to ensure paddy transplantation without the use of tube wells.
Canal water has now reached even the remotest villages, he said, adding that since assuming charge, his government has revived 15,947 water channels across Punjab.
Mann also spoke about the 'Mukhyamantri Sehat Yojana' that will provide cashless medical treatment up to Rs 10 lakh for every resident family in Punjab.
Punjab is the first state in the country to offer such comprehensive healthcare coverage, which will significantly ease the financial burden on the public while ensuring quality health services, the chief minister said.
He said agriculture and farmers have always been the top priority of his government and continuous efforts are being made to make farming profitable.
It is a matter of immense pride and satisfaction that farmers have shared that there is no shortage of electricity or canal water, and they are receiving an uninterrupted supply, the chief minister said.
Mann also handed over a cheque for Rs 1.76 crore to the village panchayat to give further impetus to development works. PTI CHS ANM RC
This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
an hour ago
- News18
Lupin launches generic medication in US
Agency: PTI Last Updated: New Delhi, Aug 11 (PTI) Drug maker Lupin on Monday said it has launched a medication, used to regulate blood glucose levels, in the US market. The company has launched Glucagon for Injection USP, 1mg/vial packaged in an emergency kit in the US, the Mumbai-based drug maker said in a statement. The company's product is bioequivalent to Eli Lilly and company's Glucagon for Injection, 1 mg/vial, it added. Glucagon is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus and as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. As per IQVIA MAT June data, Glucagon for Injection USP, 1mg/vial packaged in an emergency kit had an estimated annual sale of USD 122 million in the US. PTI MSS DRR DRR First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
News18
an hour ago
- News18
Zydus Lifesciences gets USFDA approval for angina, high blood pressure drug
New Delhi, Aug 11 (PTI) Zydus Lifesciences on Monday said it has received approval from the US health regulator to market a drug used to treat angina and high blood pressure. The company has received final approval from the US Food and Drug Administration (USFDA) for Diltiazem Hydrochloride tablets in strengths of 30 mg, 60 mg, 90 mg, and 120 mg, the drug maker said in a statement. Diltiazem Hydrochloride Tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm. It belongs to a class of drugs called calcium-channel blockers. Diltiazem works by relaxing blood vessels, which reduces the workload on the heart and increases blood and oxygen supply to the heart muscle. As per IQVIA MAT June 2025 data, Diltiazem Hydrochloride Tablets had annual sales of USD 13.9 million in the US. PTI MSS DRR view comments First Published: August 11, 2025, 13:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
New Indian Express
2 hours ago
- New Indian Express
Guntur GGH to offer free liver transplants
GUNTUR: Guntur Government General Hospital (GGH) is set to become the first government hospital in Andhra Pradesh to offer free liver transplantation surgeries to economically disadvantaged patients. The surgeries are expected to begin by October, while free knee replacement procedures will resume by mid-August after a prolonged interval. This initiative marks a significant milestone for public healthcare in the state. With the recent issuance of the Jeevandan AP Deceased Donor Certificate, GGH is now authorized to perform organ transplants using organs from deceased donors. Patients registered for liver transplants will be treated based on a waiting list to ensure transparency and fairness. Speaking to TNIE, GGH Superintendent Dr. SSV Ramana confirmed that the groundwork is nearly complete. 'Both knee and liver transplant surgeries will commence shortly, restoring access to life-saving treatment for patients unable to afford private care,' he said. To support this initiative, the hospital has set up two dedicated operation theaters at a cost of Rs.10 lakh and appointed three transplant coordinators. A team of specialists in general medicine, hepatology, anesthesia, and surgery has undergone intensive training under the guidance of Dr. Rajnikanth, a senior liver transplant expert from Chennai. GGH performs 22 kidney transplants Awareness campaigns have also been launched to promote organ donation, although only deceased donor transplants are currently permitted. GGH has a track record of performing complex surgeries, including a successful heart transplant in 2016, the first of its kind in a state-run facility. Since then, the hospital has performed 22 kidney transplants and several knee replacements. However, all transplant services were suspended during the COVID-19 pandemic and have not resumed until now. The liver transplant program, which was long in the pipeline, was delayed due to administrative and logistical hurdles. With approvals and infrastructure now in place, officials say the hospital is finally ready to offer this critical service to the underprivileged.
